The present study demonstrated that xyloketal B could reduce the aortic atherosclerotic lesion area in the entire aorta and aortic sinus in a concentration dependent manner, and thus alleviate the development of atherosclerotic plaques in apoE−/− mice, suggesting it may have potential for treatment of atherosclerosis. Here, APOE is linked to atherosclerosis.